Completed PHASE2 INTERVENTIONAL NCT00492700

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis (FLIRT)

Sponsor: Association pour la Recherche sur les Maladies Hépatiques Virales

Conditions Non Alcoholic Steatohepatitis

Updated 5 times since 2017 Last updated: Jun 26, 2007 Started: Jan 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Non Alcoholic Steatohepatitis, this trial is completed. The trial is conducted by Association pour la Recherche sur les Maladies Hépatiques Virales and has accumulated 5 data snapshots since 2003. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Association pour la Recherche sur les Maladies Hépatiques Virales

Data source: Association pour la Recherche sur les Maladies Hépatiques Virales

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France